The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

This study has been terminated.
(Study no longer feasible as quantitative assessment of fFN can only be performed at one laboratory.)
Sponsor:
Information provided by (Responsible Party):
Wendy Kinzler, MD, Winthrop University Hospital
ClinicalTrials.gov Identifier:
NCT01279369
First received: January 14, 2011
Last updated: January 9, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)